<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00620490</url>
  </required_header>
  <id_info>
    <org_study_id>4068</org_study_id>
    <nct_id>NCT00620490</nct_id>
  </id_info>
  <brief_title>Paravertebral Analgesia Associated With Intravenous Morphine PCA After Thoracotomy</brief_title>
  <official_title>Postoperative Analgesia After Thoracotomy Without Thoracic Epidural Analgesia : Paravertebral Analgesia With a Catheter Associated With Intravenous Morphine Patient-controlled-analgesia (Pca)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      osteolateral thoracotomy is a painful surgical procedure.Thoracic epidural analgesia (TEA) is&#xD;
      usually considered as the &quot;gold standard&quot; for postoperative thoracic analgesia.&#xD;
      Unfortunately, it's not always possible to realize it because of contraindications or because&#xD;
      of technical failures.Analgesia using a paravertebral block is an alternative to the TEA : it&#xD;
      provides an unilateral sensitive and sympathetic block using a catheter.In our study, the&#xD;
      catheter will be placed by the thoracic surgeon at the end of the surgical procedure, under&#xD;
      direct vision, to insure maximal security also on patients on antiplatelets agents,&#xD;
      anticoagulants or with haemostasis disorders (the placement of the catheter by the&#xD;
      anaesthetist with the loss of resistance technique is contraindicated in these&#xD;
      cases).Patients will be randomized to receive either a continuous 48-hours infusion of&#xD;
      ropivacaine 0,5% or saline serum in the control group.All patients are connected to a PCA&#xD;
      pump with intravenous morphine and will receive paracetamol and nefopam.The visual analogic&#xD;
      scale (VAS) at rest and on movement, total morphine consumption and side effects will be&#xD;
      recorded during the first 48 hours after surgery. The aim of this study is to prove a&#xD;
      decrease of pain at rest and on movement, a decrease of the cumulated total morphine dose&#xD;
      consumption and a decrease of the side effects (nausea, vomiting, pruritus, sedation,&#xD;
      bradypnea, urinary retention).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>first 48 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>· Total dosis of morphine consumption, side effects nausea, vomiting,pruritus,Urinary retention, respiratory rate and sedation, · heart rate, blood pressure and peripheral saturation</measure>
    <time_frame>first 48 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ropivacaine 0.5% 0.1 ml/kg per hour</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine</intervention_name>
    <description>Ropivacaine 0.5% 0.1 ml/kg per hour</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nacl 0,9%</intervention_name>
    <description>saline 0.9% 0.1 ml/kg per hour</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for thoracotomy who presented with contraindications to&#xD;
             TEA.Contraindications to TEA are :&#xD;
&#xD;
          -  Patient's refusal after informations about advantages and risks of the technique&#xD;
&#xD;
          -  Anti platelets treatment that can't be discontinued&#xD;
&#xD;
          -  Anticoagulants at a curative dosage- haemostasis and/or coagulation disorders:&#xD;
             thrombopenia &lt; 100.000/mm3, ACT &gt; 1,5 / control, PTT &lt; 75%- Systemic or local&#xD;
             infection of the puncture point&#xD;
&#xD;
          -  2 and 3 grade atrio-ventricular heart block without pacing&#xD;
&#xD;
          -  Severe aortic valve stenosis&#xD;
&#xD;
          -  Kyphoscoliosis&#xD;
&#xD;
          -  certain neurological disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient's refusal to participate in the study&#xD;
&#xD;
          -  Psychiatric disorder (impossibility to collect the informed consent)&#xD;
&#xD;
          -  Patient under juridical protection&#xD;
&#xD;
          -  On going an other study&#xD;
&#xD;
          -  Pregnancy, breastfeeding&#xD;
&#xD;
          -  Non balanced epilepsy&#xD;
&#xD;
          -  3 grade auriculae-ventricular heart block without pacing&#xD;
&#xD;
          -  Severe hepatocellular insufficiency&#xD;
&#xD;
          -  Anti arrhythmic treatment : class III of the Vaughan William's classification- Skin&#xD;
             infection of the puncture point&#xD;
&#xD;
          -  Allergy to aminoamides local anaesthetic&#xD;
&#xD;
          -  Surgical difficulties to insert paravertebral catheter&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Helms, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Chirurgie Thoracique, Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <study_first_submitted>February 7, 2008</study_first_submitted>
  <study_first_submitted_qc>February 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2008</study_first_posted>
  <last_update_submitted>June 25, 2010</last_update_submitted>
  <last_update_submitted_qc>June 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Emmanuel Lavoué, Directeur adjoint de la recherche clinique et de l'innovation</name_title>
    <organization>Hôpitaux Universitaires de Strasbourg</organization>
  </responsible_party>
  <keyword>Epidural analgesia</keyword>
  <keyword>Contraindications</keyword>
  <keyword>Paravertebral nerve block analgesia</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>Visual analogical scale</keyword>
  <keyword>Morphine</keyword>
  <keyword>Side effects</keyword>
  <keyword>Pain and thoracotomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

